CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression
Abstract Metastatic prostate cancer (PCa) poses a significant therapeutic challenge with high mortality rates. Utilizing CRISPR-Cas9 in vivo, we target five potential tumor suppressor genes (Pten, Trp53, Rb1, Stk11, and RnaseL) in the mouse prostate, reaching humane endpoint after eight weeks withou...
Main Authors: | Huiqiang Cai, Bin Zhang, Johanne Ahrenfeldt, Justin V. Joseph, Maria Riedel, Zongliang Gao, Sofie K. Thomsen, Ditte S. Christensen, Rasmus O. Bak, Henrik Hager, Mikkel H. Vendelbo, Xin Gao, Nicolai Birkbak, Martin K. Thomsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-46370-0 |
Similar Items
-
Computational Analysis Reveals the Temporal Acquisition of Pathway Alterations during the Evolution of Cancer
by: Johanne Ahrenfeldt, et al.
Published: (2022-11-01) -
The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy.
by: Johanne Ahrenfeldt, et al.
Published: (2023-01-01) -
['ODAM and the Construction of a Modern Spirit']
by: Edite Rosa
Published: (2012-07-01) -
ODAM – A CONSTRUÇÃO DO MODERNO EM PORTUGAL: ENTRE O UNIVERSAL E O SINGULAR / ODAM – The construction of the modern in Portugal: between universal and singular
by: Edite Maria Figueiredo e Rosa
Published: (2014-11-01) -
Comparative Analysis of Stk11/Lkb1 versus Pten Deficiency in Lung Adenocarcinoma Induced by CRISPR/Cas9
by: Martin F. Berthelsen, et al.
Published: (2021-02-01)